Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Organoheterocyclic compounds
  6. Indoles and derivatives
  7. LY 225910, Tocris Bioscience™

LY 225910, Tocris Bioscience™

Catalog No. p-4783609 Shop All R&D Systems Products
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Description

Potent CCK2 antagonist

Potent CCK2 receptor antagonist (IC50 = 9.3 nM for inhibition of 125I-labeled CCK-8 sulfate binding at mouse brain membranes).

Chemical Identifiers

CAS 133040-77-4
Molecular Formula C27H24BrN3O2
Molecular Weight (g/mol) 502.41
MDL Number MFCD00907856
InChI Key KUECXUACQOYKNB-UHFFFAOYSA-N
Synonym chembl37312, 2-2-5-bromo-1h-indol-3-yl ethyl-3-3-1-methylethoxy phenyl-4-3h-quinazolinone, 2-2-5-bromo-1h-indol-3-yl ethyl-3-3-isopropoxyphenyl quinazolin-4-one, tocris-1018, ly hplc, 2-2-5-bromoindol-3-yl ethyl-3-3-isopropoxyphenyl-4-quinazolinone, 2-2-5-bromo-1h-indol-3-yl ethyl-3-3-isopropoxyphenyl quinazolin-4 3h-one, 2-2-5-bromo-1h-indol-3-yl-ethyl-3-3-isopropoxy-phenyl-3h-quinazolin-4-one, 2-2-5-bromo-1h-indol-3-yl ethyl-3-3-propan-2-yloxyphenyl quinazolin-4-one
PubChem CID 4355450
IUPAC Name 2-[2-(5-bromo-1H-indol-3-yl)ethyl]-3-[3-(propan-2-yloxy)phenyl]-3,4-dihydroquinazolin-4-one
SMILES CC(C)OC1=CC=CC(=C1)N1C(CCC2=CNC3=CC=C(Br)C=C23)=NC2=CC=CC=C2C1=O

Specifications

Quantity 10 mg
Formula Weight 502.41
Percent Purity >98%
Chemical Name or Material LY 225910

Safety and Handling

Recommended Storage Desiccate at -20°C
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.